Medistim ASA is a medical techonology company with a near monopoly within their niche and a razor-blade business model.

In a more than 50% draw-down due to macro-economic factors, this is a secular compounder available at a reasonable price. At a 4% FCF-yield, the company is in position to deliver double digit growth for the foreseeable future. The company has great margins, 30% ROE, and no need to retain earnings in order to grow.

Not financial advice, just my opinion on an interesting company.